Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for the Treatment of Knee Osteoarthritis
NCT07547735Phase 2Recruiting
- Start
- Mar 2025
- Primary completion
- May 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human umbilical cord derived mesenchymal stem cells in knee osteoarthritis (OA) (3 arms). Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 48 weeks. Started Mar 2025; status: recruiting.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07547735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07547735.